Opendata, web and dolomites

IL7sigNETure SIGNED

IL-7/IL-7R signaling networks in health and malignancy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 IL7sigNETure project word cloud

Explore the words cloud of the IL7sigNETure project. It provides you a very rough idea of what is the project "IL7sigNETure" about.

cell    reveal    transduction    lymphoblastic    vivo    move    single    interleukin    gained    biology    intervention    gaining    chronic    relevance    view    cancer    normal    scope    settings    throughput    multidisciplinary    networks    employ    constitute    informing    gain    biological    acute    complementary    promotes    network    aggressive    rheumatoid    infection    illuminate    once    characterization    mechanisms    therapies    full    autoimmunity    landscape    arsenal    extend    multiple    breast    pathological    strategy    centered    platform    insights    fine    lung    therapeutic    molecular    generate    arthritis    downstream    experimentation    levels    leukemia    display    regulation    molecule    effectors    signaling    models    hiv    cells    overcome    receptor    showed    deregulation    function    complemented    tumor    extraordinary    cancers    signal    limited    il7    despite    data    implicated    patients    fundamental    il7r    tuned    axis    sclerosis    holistic    wired    transformation    hematological    profound    mutations    activation    inflammation   

Project "IL7sigNETure" data sheet

The following table provides information about the project.

Coordinator
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES 

Organization address
address: AVENIDA PROF EGAS MONIZ
city: LISBOA
postcode: 1649 028
website: www.imm.ul.pt

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Portugal [PT]
 Project website https://imm.medicina.ulisboa.pt/en/investigacao/labs/barata-joao-t-lab/
 Total cost 1˙988˙125 €
 EC max contribution 1˙988˙125 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-CoG
 Funding Scheme ERC-COG
 Starting year 2015
 Duration (year-month-day) from 2015-09-01   to  2020-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES PT (LISBOA) coordinator 1˙988˙125.00

Map

 Project objective

Deregulation of signal transduction is a feature of tumor cells and signaling therapies are gaining importance in the growing arsenal against cancer. However, their full potential can only be achieved once we overcome the limited knowledge on how signaling networks are wired in cancer cells. Interleukin 7 (IL7) and its receptor (IL7R) are essential for normal T-cell development and function. However, they can also promote autoimmunity, chronic inflammation and cancer. We showed that patients with T-cell acute lymphoblastic leukemia (T-ALL), an aggressive hematological cancer, can display IL7R gain-of-function mutations leading to downstream signaling activation and cell transformation. Despite the biological relevance of IL7 and IL7R, the characterization of their signaling effectors remains limited. Here, we propose to move from the single molecule/pathway-centered analysis that has characterized the research on IL7/IL7R signaling, into a ‘holistic’ view of the IL7/IL7R signaling landscape. To do so, we will employ a multidisciplinary strategy, in which data from complementary high throughput analyses, informing on different levels of regulation of the IL7/IL7R signaling network, will be integrated via a systems biology approach, and complemented by cell and molecular biology experimentation and state-of-the-art in vivo models. The knowledge we will generate should have a profound impact on the understanding of the fundamental mechanisms by which IL7/IL7R signaling promotes leukemia and reveal novel targets for fine-tuned therapeutic intervention in T-ALL. Moreover, the scope of insights gained should extend beyond leukemia. Our in-depth, systems-level characterization of IL7/IL7R signaling will constitute a platform with extraordinary potential to illuminate the molecular role of the IL7/IL7R axis in other cancers (e.g. breast and lung) and pathological settings where IL7 has been implicated, such as HIV infection, multiple sclerosis and rheumatoid arthritis.

 Publications

year authors and title journal last update
List of publications.
2017 F Buontempo, J A McCubrey, E Orsini, M Ruzzene, A Cappellini, A Lonetti, C Evangelisti, F Chiarini, C Evangelisti, J T Barata, A M Martelli
Therapeutic targeting of CK2 in acute and chronic leukemias
published pages: 1-10, ISSN: 0887-6924, DOI: 10.1038/leu.2017.301
Leukemia 32/1 2019-06-06
2017 Mariana L. Oliveira, Padma Akkapeddi, Isabel Alcobia, Afonso R. Almeida, Bruno A. Cardoso, Rita Fragoso, Teresa L. Serafim, João T. Barata
From the outside, from within: Biological and therapeutic relevance of signal transduction in T-cell acute lymphoblastic leukemia
published pages: 10-25, ISSN: 0898-6568, DOI: 10.1016/j.cellsig.2017.06.011
Cellular Signalling 38 2019-06-06
2018 Mariana L. Oliveira, Padma Akkapeddi, Daniel Ribeiro, Alice Melão, João T. Barata
IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update
published pages: , ISSN: 2212-4926, DOI: 10.1016/j.jbior.2018.09.012
Advances in Biological Regulation 2019-04-18
2018 Daniel Ribeiro, Alice Melão, Ruben van Boxtel, Cristina I. Santos, Ana Silva, Milene C. Silva, Bruno A. Cardoso, Paul J. Coffer, João T. Barata
STAT5 is essential for IL-7–mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells
published pages: 2199-2213, ISSN: 2473-9529, DOI: 10.1182/bloodadvances.2018021063
Blood Advances 2/17 2019-04-18
2016 Alice Melão, Maureen Spit, Bruno A. Cardoso, João T. Barata
Optimal interleukin-7 receptor-mediated signaling, cell cycle progression and viability of T-cell acute lymphoblastic leukemia cells rely on casein kinase 2 activity
published pages: 1368-1379, ISSN: 0390-6078, DOI: 10.3324/haematol.2015.141143
Haematologica 101/11 2019-06-06

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IL7SIGNETURE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IL7SIGNETURE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

HyperBio (2019)

Vis-NIR Hyperspectral imaging for biomaterial quality control

Read More  

ENTRAPMENT (2019)

Septins: from bacterial entrapment to cellular immunity

Read More  

OSIRIS (2020)

Automatic measurement of speech understanding using EEG

Read More